Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

homeHome
play_circleCurrent Issuecheck_circleAccepted ManuscriptslistAll Issuesformat_indent_increaseIn Press ArticlessearchSearch
helpInstructions
infoJournal InformationgroupsBoards and committeesshareIndexing and Listing Sourcesshow_chartJournal Metricszoom_inOpen Peer Review (OPR)balancePublication Ethics and Malpractice Statementmenu_bookReviewer and AE Registration FormemailSupportphoneContact Us
format_list_bulletedAPC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)

1. COVID-19, interferons, and depression: A commentary

- Shader R.I. , et al.

2. Psychiatric side effects of pegylated interferon-α and ribavirin therapy in iranian patients with chronic hepatitis c: A meta-analysis

- Davoodi L. , et al.

3. A cost-utility analysis of different antiviral medicine regimens in patients with chronic hepatitis c virus genotype 1 infection

- Alavian S.M. , et al.

4. Interleukin-28b (rs12979860) gene variation and treatment outcome after peginterferon plus ribavirin therapy in patients with genotype 1 of hepatitis C virus

- Kalantari H. , et al.

5. Evaluated outcomes in patients with chronic hepatitis C

- Ashtari S. , et al.

6. Cost-effectiveness analysis of adding low dose ribavirin to peginterferon alfa-2a for treatment of chronic hepatitis C infected thalassemia major patients in Iran

- Mehrazmay A. , et al.

7. Real Response to Therapy in Chronic Hepatitis C Virus Patients: A study from Iran

- Namazee N. , et al.